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Abstract 
Smallpox is an infectious disease unique to humans, caused by a poxvirus. It is one of the 
most lethal of diseases; the virus variant Variola major has a mortality rate of 30%. People 
surviving this disease have lifelong consequences, but also assured immunity. Historically, 
smallpox was recognised early in human populations. This led to prevention attempts: 
variolation, quarantine and the isolation of infected subjects, until Jenner’s discovery of the 
first steps of vaccination in the 18th century. After vaccination campaigns throughout the 19th 
and 20th centuries, the World Health Organization declared the eradication of smallpox in 
1980. With the development of microscopy techniques, the structural characterisation of the 
virus began in the early 20th century. In 1990 the genomes of different smallpox viruses were 
determined; viruses could be classified in order to investigate their origin, diffusion and 
evolution. To study the evolution and possible re-emergence of this viral pathogen, however, 
researchers can only use viral genomes collected during the 20th century. Cases of smallpox in 
ancient periods are sometimes well-documented, so paleomicrobiology and more precisely, 
the study of ancient smallpox viral strains could be an exceptional opportunity.  The analysis 
of poxvirus fragmented genomes could give new insights on the genetic evolution of the 
poxvirus. Recently, small fragments of the poxvirus genome were detected. With the genetic 
information obtained, a new phylogeny of smallpox virus was described.  The interest of 
conducting studies on ancient strains is discussed, in order to explore the natural history of 
this disease. 
 
 
 
 
 
3 
 
Introduction 
 
Smallpox (variola) is an acute infectious disease of viral origin (genus Orthopoxvirus), which 
has caused devastating epidemics. During the 20th century it was responsible for 300-500 
million mortalities, and in the last millennia it is estimated to have been responsible for 10% 
of mortalities worldwide. Thus, it is highly probably that this disease has strongly selected 
human populations, but there is no current evidence to validate this hypothesis. Following a 
global pandemic in the 18th century, vaccination against smallpox began in the early 19th 
century and the last case was reported in Somalia in 1977. In 1980, the World Health 
Organization (WHO) declared that smallpox had been eradicated. It is not clear what role 
population selection and the general improvement of hygiene conditions played in this 
eradication process, but the extensive vaccination programme conducted by the WHO 
certainly accelerated the process (www.who.int/csr/disease/smallpox/en/). In the modern era, 
although populations worldwide have been affected by smallpox, it is the isolated non-
occidental populations which have been impacted the most; some New World and Siberian 
populations have been decimated by the virus. 
 
Today, the study of smallpox has various challenges: (i) Social and medical challenges. Many 
populations living in remote areas, where smallpox has become endemic only recently, will 
migrate to live in urban or sub-urban environments. Thus, minor cases of the disease could 
result in epidemics through the gradual reduction in the number of vaccinated people, and the 
major environmental changes that impact them. Moreover, humans are the only known 
reservoir of the virus, but the emergence of an animal reservoir or a very closely related 
animal virus that could adapt to humans is not excluded. Note, that current-day animal 
poxvirus strains can infect humans, but that virulence differs between strains [1]. 
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Governments must therefore control live strains of the poxvirus (see below), remain informed 
on the hazards of the virus, its mutation potential during epidemics (which can speed up the 
epidemic and/or make it last longer), and the potential for competition between different 
strains. It is also necessary to identify these strains, and to distinguish between the natural re-
emergence of the disease and its genetic manipulation in the laboratory. This is also of 
importance since smallpox could be developed for acts of bioterrorism; and (ii) It is also a 
biological challenge due to co-evolution between humans and the environment. What genes 
were selected by smallpox epidemics during human evolution? How has the virus evolved? In 
human population histories what were the relationships between the major human-killers 
(plague, tuberculosis) and smallpox? 
 
Recently, we demonstrated a case of smallpox through molecular analysis; an autochthonous 
subject who died in Yakutia, Eastern Siberia, (Figure 1), between 1628-1640 during a 
significant tuberculosis epidemic [2]. From small fragments of degraded DNA we proposed a 
new phylogeny of the virus. This research gave new perspectives on the genetic study of 
smallpox; ancient smallpox samples are now considered safe to work on due to the degraded 
nature of their DNA. There is no doubt that the discovery of ancient smallpox cases and the 
sequencing of ancient strains will give further insights into the natural history of this disease. 
 
Clinical symptoms and epidemiology 
 
Humans are the only known hosts or reservoirs of smallpox. Smallpox is one of the most 
feared diseases in the world, since its mortality rate ranges from 1% for cases of Variola 
minor, to more than 97% for hemorrhagic smallpox cases in unvaccinated subjects. The 
incubation period of 8-14 days is followed by a virus-like invasion phase (high fever, 
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shivering, arthralgia), and then by a state phase with a maculopapular rash which produces 
blisters on the 3rd day and infected pustules on the 7th day. If the subject survives, there is a 
drying phase on the 10-12th day when the scabs fall off to leave permanent scars. The patient 
will then be immunized, but the duration of this immunization period is still debated [3]. With 
the hemorrhagic form the subject dies after the first 24 hours of the invasion phase following 
bleeding of the skin and/or mucous membranes. During the 19th century, less virulent 
smallpox epidemics were recorded with a death rate of 1% in South Africa and Central 
America, where the less virulent smallpox is known as alastrim [4]. The mode of disease 
transmission is usually direct contact: the virus is transmitted primarily by the exhalation of 
patients and then by contact with skin lesions. The virus is very stable and can survive for 
years in the scabs [5]. In natural conditions, however, the virus remains pathogenic for about a 
couple of weeks. 
 
The earliest and most incontestable descriptions of smallpox appeared in the 4th century in 
China, and then later in India (7th century) and in Southwest Asia and the Mediterranean (10th 
century AD (Anno Domini) [4]. It was prevalent in southern Europe during the 13th century, 
when it starting to spread throughout Europe causing millions of deaths over the centuries [6, 
7]. In the 18th century smallpox was endemic in Europe and significant peaks in the number of 
mortalities were observed: 14,000 deaths in 1716, 20,000 in 1723 and 14,000 in 1796 in Paris 
[9], killing 10% of newborns and one in three adult patients. It decimated Amerindian 
populations during the conquest of the New World from the beginning of the 16th century [4], 
and it was the succession of smallpox epidemics and other infectious diseases imported from 
the Old World that destroyed what remained of the Inca culture [8].                                                                                                                             
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Due to its distinctive clinical symptoms, smallpox has been known as a disease ‘entity’ for 
many centuries. Campaigns against smallpox began in the absence of current scientific 
knowledge, while the causes and mechanisms of the disease were unknown. Various 
protection methods against smallpox have tried to be developed. The earliest methods, 
reported in the 10th century, were insufflation in China and cutaneous inoculation in India [4]. 
Variolation, to avoid serious smallpox, consists of an inoculation with ‘benign smallpox’ from 
the pustules of a patient. The origin of this technique is disputed, but it is known to have been 
practiced in China in the 16th century. It was imported into the West in the early 18th century 
by Lady Wortley Montagu, the wife of the Ambassador of Great Britain to Turkey [10], but it 
is likely that different techniques had existed previously in the European countryside. In 
Scotland, farmers attached wool soaked in smallpox pus around their wrists, and in some 
Italian mountains children were made to wear similarly soaked shirts [11, 12]. Results were, 
however, very random and many subjects still died despite these attempts of variolation. The 
practice was introduced into France in second half of 17th century, where it was extensively 
studied and fiercely debated (due to the dangers of inoculation), with written submissions to 
the Academy of Sciences [4]. Before 1760, European doctors replaced the needle (used in 
Turkey) with the lancet, which allowed doctors to make a deeper cut [13], but these incisions 
were either ineffective or catastrophic. After 1760, Sutton proposed a method involving a 
more superficial incision, increasing the reliability of the inoculation and hence its popularity 
[12]. 
 
From 1769, at least six people in England and Germany successfully tested the possibility of 
using the cowpox vaccine against smallpox in humans [4]. At the end of the 18th century, 
Edward Jenner, a country doctor in England with many farmer patients, noted that contact 
with livestock, particularly cows, exposed farmers to a disease transmissible to humans; 
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cowpox or vaccinia, the smallpox of cows. From the observation that milkmaids who had 
contracted cowpox did not usually contract smallpox, Jenner postulated that the pus present in 
the cowpox vesicles protected people against smallpox. Today we know that the cowpox 
vaccine is a benign disease for humans, in comparison with smallpox, but at the time it 
seemed that a convergence of ideas led to replacing the pus of smallpox with that of cowpox.  
In 1796, Jenner developed the first stages of the vaccination process: he inoculated a child 
with the pus from a farm worker’s hand who was infected with cowpox (via contact with the 
infected cow’s udders), causing a localized infection at the inoculation site. Three months 
later, he inoculated the child with smallpox; the child showed no signs of infection and so was 
immunized against the virus [4]. Over a period of twenty years, Jenner conducted systematic 
experiments which led to the establishment of the vaccination method, thus replacing 
inoculation. It should be noted, however, that at the same time as variolation and vaccination, 
procedures were taking place in Europe, the quarantine and isolation of affected individuals, 
which also reduced the spread of the disease [14, 15].  
 
In the early 19th century, vaccination against smallpox spread rapidly throughout the 
occidental world [16], and was largely responsible for the observed change in population 
demography. Before vaccination world demography is termed pre-Jenner; when considering 
several generations, for 1000 births, one-third of subjects died between birth and the age of 
one and one-third between 1 and 18 years old. After vaccination world demography is termed 
post-Jenner; an increase in the number of surviving subjects between birth and 18 years old is 
observed. If birth rates remain constant there is a population explosion, and this is what 
occurred in Europe in the 19th century due to vaccination. The world population increased to 
about 1 billion in 1800, and to more than one and a half billion in 1900 [17]. The first 
vaccination campaigns carried out in the first half of the 20th century, and the WHO screening 
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programme conducted from 1967 onwards were highly successful, and smallpox was declared 
eradicated in 1980 (the last reported case was in 1977 [4]. 
 
Initial isolation and characterization of the smallpox viruses 
Recognition of the disease and measures for its prevention were initiated early in human 
history (16th century in China), but investigations into the virus itself did not begin until the 
late 19th century with the establishment of the new science of virology. Virus particles of 
smallpox, cowpox and vaccinia were firstly identified under the microscope, then by electron 
microscopy (before any other viruses had been visualised), and their chemical compositions 
were analysed before those of animal viruses [4]. Most studies and knowledge on 
orthopoxviruses were based on the vaccinia virus. 
 
The first reports on the viral elements of vaccinia using microscopy were in 1886 by Buist 
[18] and Calmette-Guérin in 1901 [19], who observed many elementary particles in the 
stained smears and vaccine lymph of rabbit. Prowazek in 1905 and Paschen in 1906 [4] also 
showed these ‘elementary bodies’ by using different microscopy methods. It was, however, 
the work of Ledingham in 1931 [20] that demonstrated definitively that the elementary bodies 
were indeed the infectious entity in the lymph. Thereafter, the analysis of the pox virion 
structure was dependent on the processing powers of the electron microscopy. Between 1948 
and 1970, thin sections of infected cells characterized the membrane structures, the core and 
the components of the vaccinia virus [4]. 
 
The detection of nucleic acids (DNA) present in the virus, but not ribonucleic acids (RNA) 
was demonstrated in 1940 [21, 22]. In 1962, the double-stranded nature of the virus’ DNA 
and its guanine and cytosine composition was demonstrated [23]. The first genomic 
9 
 
sequences of the smallpox virus were published in the early 1990s, with the complete DNA 
sequence of the vaccinia virus [24, 25]. Thereafter, a significant effort was made to sequence 
most of the isolates which had been collected during the WHO Intensified Smallpox 
Eradication Programme (1967-1980). Currently, about 50 human genomes, as well as dozens 
of animal poxviruses, are available on the web (http://www.poxvirus.org). Thus, new insights 
on the origin, distribution and evolution of different human clades have been made [26, 27]. 
 
The virus and its evolution 
Viruses of the genus Orthopoxviridae are widespread in vertebrates and most of them are 
species specific [28, 29]. The best studied Orthopoxviridae are the poxviruses (Poxviridae), 
DNA viruses that replicate in the cell cytoplasm [30]. These include smallpox viruses 
(Variola major and Variola minor), the primate viruses (highly pathogenic to humans), and 
the bovine poxvirus (used as a vaccine against the three aforementioned viruses). The genome 
of an orthopoxvirus is a linear double-stranded DNA molecule containing approximately 200 
genes. The central region of the genome has highly conserved sequences and contains the 
majority of genes involved in transcription, mRNA biosynthesis, DNA repair and replication, 
and the modification of viral structural proteins [29, 30]. The terminal regions are variable 
and determine the specific properties of the species, the strain of the virus, and its 
immunomodulatory protein genes [31-33]. The virulence of smallpox is related to a set of 
genes that produce proteins that increase (compared with other viruses) the efficiency of the 
multiple defence mechanisms of the host organisms [34]. 
 
Following the eradication of smallpox in 1980, two conservatories holding the live viral 
strains were created: CDC in Atlanta, USA, and VECTOR in Novosibirsk, the Russian 
Federation. Although the purpose of these conservatories is regularly discussed [35], their 
10 
 
goal is to store live strains in order to establish medical and vaccination strategies in the event 
of re-emergence or bioterrorism. Currently, they store live smallpox strains which were 
collected between 1944 and 1977 [26, 36]. Their genomes have been completely sequenced 
and are open access (NCBI GenBank). These strains follow the global phylogeographic 
distribution; the first cluster groups Variola major strains from Asia, India and Africa, 
excluding the West, and the second cluster groups the two sub-clusters of West Africa and in 
South America.  
 
Several studies on the strains are being conducted by the WHO and authorized laboratories: 
tests for the diagnosis of smallpox in the laboratory, smallpox genomic studies, the 
establishment of animal models and of pathogenesis, and the development of antivirals for the 
treatment of smallpox [37]. Independent advisory experts consequently assess all smallpox 
research programmes [38]. With technological advances in high-throughput sequencing and 
the generation of whole genomes for modern strain, the origin and variability in virulence 
factors for these poxviruses are well-studied by phylogeny [26, 36]. The evolution of different 
smallpox viruses are studied using data on sequence diversity, genome structure and variation 
in coding regions [27]. The evolution and phylogeny of poxviruses specific to vertebrates are 
also studied for a better understanding of the hypotheses related to the dispersion and the date 
of the origin of these strains [39, 40]. 
 
The published phylogenetic tree found a root/tMRCA calculation for the sequences of 120 
AD (maximum) (Figure 2 in [2]; mean estimate of 928 AD for the tMRCA of all smallpox 
sequences; 5%-95% confidence range = 120 AD – 1714 AD; median = 1585 AD). This date 
is consistent with that reported in early documents on smallpox (before 1000 AD [4]), but it is 
certainly very recent considering when the disease first appeared (between 1500-1100 BC in 
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China and India [4]). Indeed, apart from the traditional descriptions of the disease, 
interpretations of certain texts and/or archaeological discoveries suggest a much earlier 
existence of the disease, especially in its cutaneous form. Observations of typical rashes have 
been identified in Egyptian mummies dating from 1100-1580 BC [4, 41, 42], and the disease 
could have struck China in 1122 BC and India in 1500 BC [4, 42]. The divergence between 
current phylogenies and archaeological evidence is related to the fact that current strains only 
represent a small part of smallpox genetic variability in the 20th century. This has several 
implications: (i) as more strains are discovered variability increases, so it probable that the 
most recent common ancestor is older than present estimations; and (ii) a large number of 
strains have disappeared during human history, or they are not detected today as they are no 
longer virulent. Strains affecting European and American human populations between the 13th 
and 18th centuries have been eradicated since the 19th century following the first vaccination 
campaigns [7]. 
 
Paleogenetic studies 
Paleomicrobiology is a field of research based on the detection of infectious diseases in the 
past [43]. Fragments of bacterial or viral DNA are searched for in possibly infected tissues, or 
in the teeth of subjects, who died during a bacteremia or viremia, taking into account the 
specific characteristics of the ancient DNA sample (Figure 3). Regarding smallpox, our work 
in Central Yakutia (Eastern Siberia) in 2004 led to the discovery of an elite burial (wealthy 
and organized) dating from between 1730 and 1740, with five remarkably well-preserved 
subjects (Figure 4). The anatomical study revealed no trauma, and the burial of subjects at the 
same time during winter suggested that they had died during a disease epidemic [44]. The 
search for pathogens was initially focused on bacterial pathogens, but since none were found 
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a viral origin was hypothesized. This was reinforced by the presence of iron in the lung 
alveoli of the subject, suggesting death due to a haemorrhage. Smallpox was not the first virus 
to be tested for, because none of the four subjects, for whose skin could be examined, showed 
any traces of blisters or pustules. Only in the best preserved subject were we able to identify 
three DNA fragments of the ancient human poxvirus by PCR [2]. To assess the persistence of 
large DNA fragments, we conducted long range PCRs on the E9l gene (encoding for 
polymerase) following [39]. The amplifications expected were about 1000 and 2043 bp: no 
positive results were obtained, suggesting a fragmented viral genome [2]. The absence of 
pustules, the presence of a pulmonary hemorrhage and the detection of the virus could 
indicate that the subject presented hemorrhagic smallpox. It would be interesting to look for 
the presence of smallpox in the other subjects in the grave (Figure 4). The first phylogenetic 
study conducted on these fragments showed, as expected (see above), that this ancient strain 
is distinct from the modern strains described previously (Figure 2). 
This study was the first of its kind – it opens up interesting avenues for phylogenic and 
natural history approaches to studying smallpox. The virus is considered resistant to 
environmental conditions, but the subject was buried in Central Yakutia where temperatures 
can drop below 50°C in winter (see conservation of burials and bodies in Figure 5), and a 
burial of two and a half centuries has destroyed the virus, fragmenting and degrading its 
DNA. It is hoped that research on archaeological samples will be facilitated in the future. 
According to current legislation and risk assessments, the theoretically level of containment 
required in a laboratory, due to the classification of a parental strain, does not necessarily need 
to be implemented. Smallpox and archaeological samples which are significantly degraded 
are not pathogenic. Thus, we can assume that a biosafety level of two would be required in a 
laboratory, corresponding to the minimum level required by the regulations for handling of 
samples of human origin (e.g., teeth). The scientific community can then use the ‘smallpox 
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model’ to assess the co-evolution of virulence and resistance genes (if they exist in humans) 
in subjects buried before, during and after an epidemic. The future of smallpox natural history 
remains to be written; it will not be dangerous, so the interest in keeping live strains of the 
virus is brought into question again. 
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Legends of figures 
Figure 1: Location of Yakutia in Siberia. Map of the three initial regions occupied by ancient 
Yakut populations excavated during MAFSO archaeological campaigns. Star shows the 
location of the shamanic tree grave © Patrice Gérard CNRS. 
Figure 2: Phylogenetic analysis of concatenated sequences of an ancient Siberian smallpox 
virus (PoxSib). These three gene segments showed that the 300 year old virus did not belong 
to the cluster of known sequenced strains of the 20th century (1946-1977). Derived from 
Figure 1b in [2]. Reprinted with permission. 
Figure 3: Composition of environmental, undetermined and potential pathogenic 16S rDNA 
sequences in ancient skeletons and frozen bodies. The majority of the bacterial pool was 
environmental bacteria originating from the soil, vegetation or permafrost characteristic of the 
Arctic. Derived from Figure 2 in [45]. Reprinted with permission. Paleogenetic studies 
conducted over more than 10 years in our laboratory have clearly demonstrated the 
persistence of fragmented DNA molecules [45, 47]. It is important to note that such 
archaeological samples consist of many DNA molecules, not only originating from the 
subject (human nuclear and mitochondrial DNA) and the pathogen potentially responsible for 
the death of the subject (bacterial or viral DNA), but also environmental bacteria from this 
complex environment: soil, water, plants. Metagenomic or bacterial genome analyzes show 
that the majority of bacteria in this kind of sample are environmental [45].  
Figure 4: Evocation of the shamanic tree grave © Nicolas Senegas; watercolour of different 
masks and capes of studied woman © Christiane Petit-Hochstrassesr. The tomb is large and 
well-organized, which shows that the population and the related subjects had not all been 
eradicated. It is interesting to note that the golden age in Yakutia ends after 1728/1740 [44, 
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46]. Originally we discussed a major economic change [44], it would be interesting to 
determine how a hemorrhagic smallpox epidemic could have participated in this decline. 
Figure 5: The frozen graves of Yakutia: an exceptional conservation. From left to right: 
Shamanic tree (2004); Kouranakh (2011); Ordiogone 2 (2007) © Patrice Gérard CNRS; 
Eletcheï 1 (2009) © Nicolas Senegas.  The main ethnic group from this region, the Yakuts, 
used inhumation as a common funerary practice ever since they discovered the region in the 
Middle Ages [44]. This is unique to Yakuts in Siberia and the Arctic, and provides a unique 
opportunity to access a continuous temporal sampling from the Middle Ages onwards. 
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